Fierce Pharma

NOVEMBER 8, 2023

In the Big Pharma battle to treat obesity, Novo Nordisk sprinted to an early lead, but Eli Lilly is catching up quickly. | In the Big Pharma battle to treat obesity, Novo Nordisk sprinted to an early lead, but Eli Lilly is catching up quickly. Wednesday's FDA approval of Lilly's Zepbound to treat obesity closes the gap further. In addition, Lilly said it will charge 20% less than Novo for its obesity med in an attempt to provide increased access.

FDA 323

FDA Pharma Leads 323

European Pharmaceutical Review

NOVEMBER 8, 2023

A paper published by Research Square has described a rapid, simple, accurate and precise high-performance liquid chromatography with diode-array detection (HPLC-DAD) method for levofloxacin determination in liquid pharmaceutical formulations. The effectiveness of levofloxacin can be impacted by its stability in pharmaceutical formulations. This impacts the effective concentration of the drug, Mohammed et al. noted.

Food and Drug Administration 110

Food and Drug Administration Pharmaceutical Food FDA 110

Fierce Pharma

NOVEMBER 8, 2023

In three years as the pharma chief at Roche, Bill Anderson executed a massive overhaul of the division, lopping off layers of management and recharting its course. | In three years as the pharma chief at Roche, Bill Anderson executed a massive overhaul of the division, lopping off layers of management and recharting its course. Now in his fifth month as CEO at struggling conglomerate Bayer, Anderson is focused on an even larger renovation, saying the company is on its way to a “radical realignme

Pharma 306

Pharma Management 306

MedCity News

NOVEMBER 8, 2023

Walgreens is seeing “an enormous amount of demand” for injectable weight loss drugs, its president of U.S. healthcare said during the Reuters Total Health conference in Chicago. He declared that the healthcare industry needs to come up with a reimbursement model “that correctly compensates pharmacists and others” to administer these drugs. In his view, reimbursement hasn’t caught up with the demand.

Healthcare 113

Healthcare Healthcare Biopharma 113

Advertisement

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

Sales Management

Fierce Pharma

NOVEMBER 8, 2023

While Biogen CEO Chris Viehbacher seems satisfied with the company's third-quarter financial metrics, the main question at the drugmaker isn’t so much how the company’s doing now, but what its plan | While Biogen CEO Chris Viehbacher seems satisfied with the company's third-quarter financial metrics, the main question at the drugmaker isn’t so much how the company’s doing now, but what its plans are for future growth, he said on a call with investors.

Sales 264

Sales 264

European Pharmaceutical Review

NOVEMBER 8, 2023

For UK patients with severe insomnia, for whom existing therapies have not worked, a new, decentralised clinical trial is set to evaluate chloral hydrate as a short-term treatment. Evaluating chloral hydrate for insomnia While chloral hydrate is already an established treatment for insomnia, much of the published clinical data in adult patients is dated, according to clinical trials company Lindus Health and global lifecycle management healthcare company Pharmanovia.

Safety 105

Safety Patients Healthcare Healthcare 105

MedCity News

NOVEMBER 8, 2023

Eli Lilly weight management drug Zepbound landed its much anticipated FDA approval. The new Lilly product is in the same drug class as Novo Nordisk weight medication Wegovy, but it offers an additional mechanism of action and costs less.

FDA 113

FDA Management Medical Biopharma 113

Fierce Pharma

NOVEMBER 8, 2023

With the goal of becoming a powerhouse in oncology, Gilead Sciences is closely tracking the progress of its two marketed CAR-T therapies. | The company attributes the gradual pace of CAR-T uptake to the "fragmentation" of the U.S. healthcare system, Kite head Cindy Perettie said on an earnings call. Together, Kite's Yescarta and Tecartus posted third-quarter sales of $487 million.

Patients 184

Patients Sales Healthcare Healthcare 184

PharmExec

NOVEMBER 8, 2023

Tirzepatide (Zepbound; Eli Lilly and Company) is expected to be available in the United States by the end of 2023 with a list price of $1,059.87.

Management 115

Management FDA 115

Fierce Pharma

NOVEMBER 8, 2023

While Novo Nordisk struggles with manufacturing concerns and patient coverage on its long-acting insulin Levemir, Bayer missed a primary endpoint in a confirmatory trial for its P13K inhibitor Aliq | While Bayer's P13K Aliqopa couldn't prove its worth in a confirmatory trial, Novo's Levemir faced manufacturing issues and troubles with patient coverage, leading the two to separately withdraw their products.

Manufacturing 130

Manufacturing Marketing Leads Patients 130

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patients

MedCity News

NOVEMBER 8, 2023

Prime members can now get a One Medical membership for $9 a month or $99 a year. The benefit provides access to 24/7 on-demand virtual care through One Medical’s app. But health experts are split on whether the move will improve access to care.

Medical 108

Medical 108

PharmaTech

NOVEMBER 8, 2023

Matthew Lauber, senior director—Cell and Gene Therapy, Consumables & Lab Automation, at Waters Corporation, considers that status of oligonucleotides on the market.

Marketing 98

Marketing 98

MedCity News

NOVEMBER 8, 2023

No matter what camp healthcare providers sit in, it’s important for them to understand how they can harness the power of responsible generative AI. Here we dive into some use cases to consider exploring and how it’s impacting healthcare – for the better.

Healthcare 109

Healthcare Healthcare Healthcare Provider Patients 109

PharmaTimes

NOVEMBER 8, 2023

Zoliflodacin inhibits the vital bacterial enzyme for bacterial function and reproduction - News - PharmaTimes

114

114

Advertisement

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

Sales

MedCity News

NOVEMBER 8, 2023

Food insecurity is a blight that affects many. According to the Department of Agriculture, 12.8 percent (17.0 million households) were food insecure. The percentage of food insecure household was statistically significantly higher than the 10.2 percent recorded in 2021 (13.5 million households) and the 10.5 percent in 2020 (13.8 million households).

Food 103

Food Distribution Manufacturing Marketing 103

PharmaTimes

NOVEMBER 8, 2023

Communicable diseases account for 50% of all deaths in LMICs - News - PharmaTimes

114

114

MedCity News

NOVEMBER 8, 2023

Forum, which launched Wednesday, is an online marketplace that offers peer support groups for a range of topics, including grief, loneliness, chronic conditions, substance use, caregiving and relationships. It has raised $5.3 million in seed funding led by NextView Ventures.

98

98

Pharmaceutical Commerce

NOVEMBER 8, 2023

Session explores how on-market products have done, and what to expect from new biosimilars.

Marketing 105

Marketing 105

Advertisement

PharmExec

NOVEMBER 8, 2023

Companies must determine the right ways to utilize AI.

115

115

Clarivate

NOVEMBER 8, 2023

For most defendants, patent litigation is a high stakes situation that justifies a significant investment in building an effective defense strategy. At the heart of any successful defensive strategy is comprehensive patent research. Recent legal decisions are heightening the need for, and in some ways, changing the focus of patent research when preparing for litigation.

Electronics 59

Electronics Food Pharmaceutical 59

PharmExec

NOVEMBER 8, 2023

The online promotion of intravenous infusions and oral forms of subanesthetic ketamine for the treatment of mental health conditions has been found to frequently carry misleading or false information.

Marketing 64

Marketing 64

pharmaphorum

NOVEMBER 8, 2023

Bayer to streamline management in cost-cutting drive Phil.

Management 104

Management 104

Advertisement

Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.

Sales

Clarify Health

NOVEMBER 8, 2023

Healthcare strategy and innovation leaders from Aetna, Contigo Health, and Clarify recently hosted a webinar discussion about innovations in provider network design and management to drive higher-value, more affordable, and more accessible care for members. Watch the recording or read the transcript for unique perspectives on the intersection of technology, provider performance, and value-based contracting.

Networking 52

Networking Management Patients Physicians 52

pharmaphorum

NOVEMBER 8, 2023

France reported to be probing Sanofi over Dupixent launch Phil.

100

100

PharmaTech

NOVEMBER 8, 2023

Matthew Lauber, senior director—Cell and Gene Therapy, Consumables & Lab Automation, at Waters Corporation highlights how current technologies are enabling oligonucleotide development.

52

52

pharmaphorum

NOVEMBER 8, 2023

NICE backs 'artifical pancreas' tech for type 1 diabetics Phil.

98

98

Advertisement

Distribution

PM360

NOVEMBER 8, 2023

iCliniq , a leading global provider of healthcare resources with operations in the U.S., U.K., UAE, India, Singapore and Germany, has named Paige Dahlhausen as its Head of Sales. The appointment of Dahlhausen marks a key milestone for the company’s dedication to female leadership with more than half of iCliniq’s 160+ global team identifying as female.

Leads 52

Leads Sales Healthcare Healthcare 52

pharmaphorum

NOVEMBER 8, 2023

Activist investor Elliott turns its attention to BioMarin Phil.

93

93

Pharmacy Times

NOVEMBER 8, 2023

Atta Chowdhry, RPh, and Robert Sidonio Jr, MD, MSc, discuss the emergence of gene therapy as an exciting option for patients with hemophilia A and highlight benefits, limitations, and ongoing research in the field.

Patients 63

Patients 63

pharmaphorum

NOVEMBER 8, 2023

Lilly gets FDA okay for tirzepatide as obesity therapy Phil.

FDA 94

FDA 94

Advertisement

Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A

Sales